Literature DB >> 19756468

[Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].

R Berges1, K Dreikorn, K Höfner, S Madersbacher, M C Michel, R Muschter, M Oelke, O Reich, W Rulf, C Tschuschke, U Tunn.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19756468     DOI： 10.1007/s00120-009-2066-5

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  99 in total

1.  Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.

Authors:  Steven J Jacobsen; Rosebud O Roberts
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

Review 2.  Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach.

Authors:  Mohammed Belal; Paul Abrams
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

Review 3.  Objective evaluation of bladder outlet obstruction.

Authors:  P Abrams
Journal:  Br J Urol       Date:  1995-07

Review 4.  The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Authors:  G S Gerber
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

5.  Predictability of conventional tests for the assessment of bladder outlet obstruction in benign prostatic hyperplasia.

Authors:  Y Homma; M Gotoh; M Takei; K Kawabe; T Yamaguchi
Journal:  Int J Urol       Date:  1998-01       Impact factor: 3.369

6.  The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology.

Authors:  P Abrams; J G Blaivas; S L Stanton; J T Andersen
Journal:  Scand J Urol Nephrol Suppl       Date:  1988

7.  The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness.

Authors:  C Manieri; S S Carter; G Romano; A Trucchi; M Valenti; A Tubaro
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

8.  Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement.

Authors:  W P Witjes; M J de Wildt; P F Rosier; C T Caris; F M Debruyne; J J de la Rosette
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

9.  Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.

Authors:  Alexander Bachmann; Leander Schürch; Robin Ruszat; Stephen F Wyler; Hans-Helge Seifert; Alexander Müller; Kurt Lehmann; Tullio Sulser
Journal:  Eur Urol       Date:  2005-07-18       Impact factor: 20.096

10.  Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial.

Authors:  Brian Hill; William Belville; Reginald Bruskewitz; Muta Issa; Ramon Perez-Marrero; Claus Roehrborn; Martha Terris; Michael Naslund
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450
View more
  11 in total

1.  [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

Authors:  K Höfner; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; T Bschleipfer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

2.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 3.  [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management].

Authors:  M Oelke; S Madersbacher
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

4.  Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy?

Authors:  Jürgen Pannek; Peter Bartel; Konrad Göcking; Angela Frotzler
Journal:  World J Urol       Date:  2012-10-17       Impact factor: 4.226

Review 5.  [Surgical treatment of male lower urinary tract symptoms (LUTS)].

Authors:  C Gratzke; F Strittmatter; O Reich; A Bachmann; C G Stief; M Seitz
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 6.  [Urodynamic testing of the lower urinary tract].

Authors:  A Reitz; C Seif; R Kirschner-Hermanns; K Höfner; M Goepel
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

7.  Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.

Authors:  Richard Berges; Matthias Oelke
Journal:  World J Urol       Date:  2011-01-08       Impact factor: 4.226

8.  [Association between residual urinary volume and urinary tract infection: prospective trial in 225 male patients].

Authors:  S Brookman-May; M Burger; B Hoschke; W F Wieland; F Kendel; C Gilfrich; K-P Braun; M May
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

9.  Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older.

Authors:  Matthias Oelke; Birgitt Wiese; Richard Berges
Journal:  World J Urol       Date:  2014-08-08       Impact factor: 4.226

10.  [Pharmacological treatment of benign prostatic hyperplasia].

Authors:  M Oelke; E Martinelli
Journal:  Urologe A       Date:  2016-01       Impact factor: 0.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.